Add like
Add dislike
Add to saved papers

Utilization of large volume zwitterionic hydrophilic interaction liquid chromatography for the analysis of polar pharmaceuticals in aqueous environmental samples: Benefits and limitations.

Benefits and limitations of HILIC were studied for the analysis of extreme polar organic contaminants in aqueous environmental matrices. A sensitive analytical method was developed and validated for the detection of 11 pharmaceuticals, 15 pharmaceutical metabolites and transformation products and the artificial sweetener acesulfame in aqueous environmental samples. The analytical method consisted of a simple and non-specific sample preparation based on freeze-drying followed by detection with large injection volume (70 μL) zwitterionic HILIC-ESI-MS/MS. Robustness studies showed a high sensitivity of the retention times and peak shapes to variations of the acetonitrile/water ratio of both the eluent and the diluent. Thus, a thorough sample and eluent preparation is required to obtain reproducible results. Extreme matrix effects of >200% were observed for emtricitabine and acyclovir, which could be traced to the co-elution of nitrate and chloride, respectively. These matrix effects and those of other analytes could be efficiently compensated by using deuterated, 13 C and 15 N-labeled internal standards. The developed method was able to detect the selected 27 analytes in treated wastewater, surface water and groundwater down to limit of quantification (LOQ) in the lower ng/L range. Appreciable concentrations were detected, ranging up to 110 μg/L (guanyl urea) in treated wastewater, up to 5.1 μg/L (oxipurinol) in surface water and up to 6.1 μg/L (acesulfame) in groundwater. In a German drinking water, only the X-ray contrast medium diatrizoate and the artificial sweetener acesulfame were quantified above LOQ with 0.19 μg/L and 0.35 μg/L, respectively.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app